Activation of CFTR by ASBT-mediated bile salt absorption

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 289, Issue 5 52-5, 2005, Pages

  Bijvelds, Marcel J C ^a   Jorna, Huub ^a   Verkade, Henkjan J ^c   Bot, Alice G M ^a   Hofmann, Franz ^d   Agellon, Luis B ^e   Sinaasappel, Maarten ^b   De Jonge, Hugo R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chloride channel; Cystic fibrosis; Intestinal fluid transport; Intestinal obstruction; Signal transduction

Indexed keywords

ANION CHANNEL; APICAL SODIUM DEPENDENT BILE ACID TRANSPORTER; BILE SALT; BUMETANIDE; CARBACHOL; CARRIER PROTEIN; CHLORIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP; HISTAMINE H1 RECEPTOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NEUROTRANSMITTER; NYSTATIN; PROSTAGLANDIN; PROTEIN INHIBITOR; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SEROTONIN; SODIUM ION; TAUROCHOLIC ACID; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; CHANNEL GATING; CONTROLLED STUDY; ILEUM; INTESTINE FLUID; INTESTINE OBSTRUCTION; INTESTINE SECRETION; ION TRANSPORT; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SODIUM TRANSPORT; WATER ABSORPTION;

ABSORPTION; ANIMALS; BILE ACIDS AND SALTS; CHLORIDES; COLON; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ILEUM; MEMBRANE POTENTIALS; MICE; MICE, KNOCKOUT; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PARACRINE COMMUNICATION; SYMPORTERS; TAUROCHOLIC ACID;

EID: 27444432273     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00226.2005     Document Type: Article

References (59)

1. +-dependent bile acid transporter is associated with cholehepatic shunting in rats. Hepatology 41: 1037-1045, 2005.
2. Alpini G, Glaser S, Robertson W, Phinizy JL, Rodgers RE, Caligiuri A, and LeSage G. Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. Am J Physiol Gastrointest Liver Physiol 273: G518-G529, 1997.
3. Alpini G, Roberts S, Kuntz SM, Ueno Y, Gubba S, Podila PV, LeSage G, and LaRusso NF. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 110: 1636-1643, 1996.
4. Bahar RJ and Stolz A. Bile acid transport. Gastroenterol Clin North Am 28: 27-58, 1999.
5. Barrett KE and Keely SJ. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol 62: 535-572, 2000.
6. Bijvelds MJC, Bronsveld I, Havinga R, Sinaasappel M, de Jonge HR, and Verkade HJ. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events. Am J Physiol Gastrointest Liver Physiol 288: G646-G653, 2005.
7. Binder HJ, Filburn C, and Volpe BT. Bile salt alteration of colonic electrolyte transport: role of cyclic adenosine monophosphate. Gastroenterology 68: 503-508, 1975.
8. Chadwick VS, Gaginella TS, Carlson GL, Debongnie JC, Phillips SF, and Hotmann AF. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Lab Clin Med 94: 661-674, 1979.
9. Chignard N, Mergey M, Veissiere D, Poupon R, Capeau J, Parc R, Paul A, and Housset C. Bile salts potentiate adenylyl cyclase activity and cAMP-regulated secretion in the human gallbladder epithelium. Am J Physiol Gastrointest Liver Physiol 284: G205-G212, 2003.
10. Cohn JA, Strong TV, Picciotto MR, Nairn AC, Collins FS, and Fitz JG. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 105: 1857-1864, 1993.
11. Colombo C, Apostolo MG, Ferrari M, Seia M, Genoni S, Giunta A, and Sereni LP. Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr 124: 393-399, 1994.
12. Colombo C, Battezzati PM, Crosignani A, Morabito A, Costantini D, Padoan R, and Giunta A. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 36: 1374-1382, 2002.
13. Colombo C, Battezzati PM, Strazzabosco M, and Podda M. Liver and biliary problems in cystic fibrosis. Semin Liver Dis 18: 227-235, 1998.
14. Cooke HJ, Nemeth PR, and Wood JD. Histamine action on guinea pig ileal mucosa. Am J Physiol Gastrointest Liver Physiol 246: G372-G377, 1984.
15. Corazza GR, Ciccarelli R, Caciagli F, and Gasbarrini G. Cyclic AMP and cyclic GMP levels in human colonic mucosa before and during chenodeoxycholic acid therapy. Gut 20: 489-492, 1979.
16. Dawson PA, Haywood J, Craddock AL, Wilson M, Tietjen M, Kluckman K, Maeda N, and Parks JS. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J Biol Chem 278: 33920-33927, 2003.
17. 3-mediated release of calcium from intracellular stores in a colonic cell line (T84). J Clin Invest 92: 2173-2181, 1993.
18. Dommelen van FS, Hamer CM, and de Jonge HR. Efficient entrapment of large and small compounds during vesiculation of intestinal microvilli. Biochem J 236: 771-778, 1986.
19. Doorninck van JH, French PJ, Verbeek E, Peters RH, Morreau H, Bijman J, and Scholte BJ. A mouse model for the cystic fibrosis ΔF508 mutation. EMBO J 14: 4403-4411, 1995.
20. Eggermont E. Gastrointestinal manifestations in cystic fibrosis. Eur J Gastroenterol Hepatol 8: 731-738, 1996.
21. Fitz JG, Basavappa S, McGill J, Melhus O, and Cohn JA. Regulation of membrane chloride currents in rat bile duct epithelial cells. J Clin Invest 91: 319-328, 1993.
22. Fondacaro JD, Heubi JE, and Kellogg FW. Intestinal bile acid malabsorption in cystic fibrosis: a primary mucosal cell defect. Pediatr Res 16: 494-498, 1982.
23. Forte LR and Currie MG. Guanylin: a peptide regulator of epithelial transport. FASEB J 9: 643-650, 1995.
24. French PJ, van Doorninck JH, Peters RH, Verbeek E, Ameen NA, Marino CR, de Jonge HR, Bijman J, and Scholte BJ. A ΔF508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J Clin Invest 98: 1304-1312, 1996.
25. Fromm D and Halpern N. Effects of histamine receptor antagonists on ion transport by isolated ileum of the rabbit. Gastroenterology 77: 1034-1038, 1979.
26. Gelbmann CM, Schteingart CD, Thompson SM, Hofmann AF, and Barrett ICE. Mast cells and histamine contribute to bile acid-stimulated secretion in the mouse colon. J Clin Invest 95: 2831-2839, 1995.
27. Grubb BR and Boucher RC. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 79: S193-S214, 1999.
28. Hardcastle J, Hardcastle PT, Chapman J, and Taylor CJ. Taurocholic acid-induced secretion in normal and cystic fibrosis mouse ileum. J Pharm Pharmacol 53: 711-719, 2001.
29. Hofmann AF. Biliary secretion and excretion. The hepatobiliary component of the enterohepatic circulation of bile acids. In: Physiology of the Gastrointestinal Tract (3rd ed.), edited by Johnson LR. New York: Raven, 1994, p. 1555-1576.
30. Hofmann AF. Intestinal absorption of bile acids and biliary constituents. In: Physiology of the Gastrointestinal Tract (3rd ed.), edited by Johnson LR. New York: Raven, 1994, p. 1845-1865.
31. - secretion in T84 cells. Am J Physiol Cell Physiol 264: C671-C676, 1993.
32. Keely SJ and Barrett KE. Regulation of chloride secretion. Novel pathways and messengers. Ann NY Acad Sci 915: 67-76, 2000.
33. Krag E and Phillips SF. Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum. J Clin Invest 53: 1686-1694, 1974.
34. Kramer W, Wess G, Baringhaus KH, Böger G, Enhsen A, Falk E, Friedrich M, Glombik H, Hofmann AF, Neckermann G, Pittius C, Schäfer HL, and Urmann M. Design and properties of ileal bile acid transport inhibitors. In: Falk Symposium 80: Bile Acids in Gastroenlerology. Basic and Clinical Advances, edited by Hofmann AF, Paumgartner G, and Stiehl A. Dordrecht, The Netherlands: Kluwer, 1995, p. 205-220.
35. Lamireau T, Monnereau S, Martin S, Marcotte JE, Winnock M, and Alvarez F. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol 41: 920-925, 2004.
36. Lewis MC and Root C. In vivo transport kinetics and distribution of taurocholate by rat ileum and jejunum. Am J Physiol Gastrointest Liver Physiol 259: G233-G238, 1990.
37. Markert T, Vaandrager AB, Gambaryan S, Pöhler D, Häusler C, Walter U, de Jonge HR, Jarchau T, and Lohmann SM. Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator. J Clin Invest 96: 822-830, 1995.
38. Maurage C, Lenaerts C, Weber A, Brochu P, Yousef I, and Roy CC. Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis. J Pediatr Gastroenterol Nutr 9: 17-20, 1989.
39. Mekhjian HS, Phillips SF, and Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest 50: 1569-1577, 1971.
40. O'Brien S, Mulcahy H, Fenlon H, O'Broin A, Casey M, Burke A, FitzGerald MX, and Hegarty JE. Intestinal bile acid malabsorption in cystic fibrosis. Gut 34: 1137-1141, 1993.
41. Quist RG, Ton-Nu HT, Lillienau J, Hofmann AF, and Barrett KE. Activation of mast cells by bile acids. Gastroenterology 101: 446-456, 1991.
42. +-ATPase. Am J Med Sci 279: 141-146, 1980.
43. Ratcliff R, Evans MJ, Cuthbert AW, MacVinish LJ, Foster D, Anderson JR, and Colledge WH. Production of a severe cystic fibrosis mutation in mice by gene targeting. Nat Genet 4: 35-41, 1993.
44. Roda A, Hofmann AF, and Mysels KJ. The influence of bile salt structure on self-association in aqueous solutions. J Biol Chem 258: 6362-6370, 1983.
45. Scholte BJ, Davidson DJ, Wilke M, and de Jonge HR. Animal models of cystic fibrosis. J Cyst Fibros 3, Suppl 2: 183-190, 2004.
46. - currents in a biliary cell line. Gastroenterology 109: 965-972, 1995.
47. Sokol RJ and Durie PR. Recommendations for management of liver and biliary tract disease in cystic fibrosis. J Pediatr Gastroenterol Nutr 28: S1-S13, 1999.
48. Thomsson KA, Hinojosa-Kurtzberg M, Axelsson KA, Domino SE, Lowe JB, Gendler SJ, and Hansson GC. Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced fucalphal-2 glycosyltransferase. Biochem J 367: 609-616, 2002.
49. Torchia EC, Stolz A, and Agellon LB. Differential modulation of cellular death and survival pathways by conjugated bile acids. BMC Biochem 2: 11, 2001.
50. Vaandrager AB, Bot AG, and de Jonge HR. Guanosine 3′,5′- cyclic monophosphate-dependent protein kinase II mediates heat-stable enterotoxin-provoked chloride secretion in rat intestine. Gastroenterology 112: 437-443, 1997.
51. Vaandrager AB, Bot AG, Ruth P, Pfeifer A, Hofmann F, and de Jonge HR. Differential role of cyclic GMP-dependent protein kinase II in ion transport in murine small intestine and colon. Gastroenterology 118: 108-114, 2000.
52. 4. Nature 371: 711-714, 1994.
53. - transport. Am J Physiol Cell Physiol 280: C646-C658, 2001.
54. Wall MJ and Baker RD. Effect of taurocholate on electrical potential difference across rat small intestine. Life Sci 11: 375-386, 1972.
55. Wall MJ and Baker RD. Intestinal transmural electrical properties: effects of conjugated bile salt in vitro. Am J Physiol 227: 499-506, 1974.
56. - secretion. I. Effect of histamine on the T84 cell line. Am J Physiol Cell Physiol 254: C53-C62, 1988.
57. Weinman SA, Carruth MW, and Dawson PA. Bile acid uptake via the human apical sodium-bile acid cotransporter is electrogenic. J Biol Chem 273: 34691-34695, 1998.
58. Wilschanski M, Rivlin J, Cohen S, Augarten A, Blau H, Aviram M, Bentur L, Springer C, Vila Y, Branski D, Kerem B, and Kerem E. Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics 103: 52-57, 1999.
59. 2+- and PKC-dependent stimulation of PGE2 synthesis by deoxycholic acid in human colonic fibroblasts. Am J Physiol Gastrointest Liver Physiol 283: G503-G510, 2002.